Home › Stocks › FDMT › All Fund Holders
FDMT — 4D MOLECULAR THERAPEUTICS IN · All Fund Holders
Funds holding (latest): 42 · Reported value held: $388.37M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Viking Global Investors history | Q2 2024 | 2.93M | $61.60M | 0.24% | Hold |
| BlackRock Inc history | Q2 2026 | 4.55M | $60.46M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 4.26M | $56.64M | 0.01% | Add |
| Janus Henderson Group history | Q1 2026 | 5.25M | $48.87M | 0.02% | Add |
| Vanguard Group history | Q4 2025 | 3.09M | $23.20M | 0.00% | Add |
| Alkeon Capital Management history | Q3 2021 | 602.23K | $16.24M | 0.03% | New |
| Geode Capital Management history | Q2 2026 | 1.13M | $15.01M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 1.12M | $14.90M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 901.20K | $11.99M | 0.00% | Add |
| Point72 Asset Management history | Q4 2025 | 1.54M | $11.55M | 0.01% | New |
| Deutsche Bank AG history | Q2 2026 | 710.94K | $9.46M | 0.00% | Hold |
| Renaissance Technologies history | Q2 2026 | 614.57K | $8.17M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 562.93K | $7.49M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 503.02K | $6.69M | 0.00% | Add |
| Casdin Capital history | Q4 2024 | 1.15M | $6.41M | 0.43% | Hold |
| JPMorgan Chase & Co history | Q2 2026 | 402.14K | $5.18M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 339.27K | $4.51M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 256.67K | $3.41M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 152.34K | $2.03M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 150.38K | $2.00M | 0.00% | Reduce |
| Soros Fund Management history | Q1 2024 | 62.50K | $1.99M | 0.04% | New |
| Wellington Management Group history | Q2 2026 | 128.46K | $1.71M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 128.32K | $1.71M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 69.48K | $924.10K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 69.21K | $920.52K | 0.00% | Add |
| Millennium Management history | Q4 2025 | 96.36K | $722.73K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 50.28K | $668.74K | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 44.35K | $589.91K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 41.73K | $555.04K | 0.00% | Add |
| Principal Global Investors history | Q2 2024 | 21.03K | $441.50K | 0.00% | Add |
| Royce & Associates history | Q4 2023 | 18.77K | $380.26K | 0.00% | New |
| CPP Investments history | Q2 2026 | 24.70K | $328.51K | 0.00% | New |
| Franklin Resources history | Q3 2024 | 34.78K | $314.07K | 0.00% | Reduce |
| Balyasny Asset Management history | Q3 2022 | 37.04K | $298.00K | 0.00% | New |
| Marshall Wace history | Q2 2026 | 21.34K | $283.85K | 0.00% | Add |
| Prudential Financial history | Q1 2024 | 8.63K | $275.08K | 0.00% | New |
| Norges Bank Investment Management history | Q2 2025 | 54.22K | $201.15K | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 12.49K | $166.10K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 4.45K | $59.16K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 1.48K | $19.71K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 54.87K | $730 | 0.00% | Add |
| Lazard Asset Management history | Q4 2024 | 26 | $0 | — | Hold |